Skip to content

Relation Between NLR and IMR in STEMI Patients

Relationships Between Neutrophil-to-Lymphocyte Ratio and Index of Microcirculatory Resistance in ST-segment Elevation Myocardial Infarction Patients Undergone Primary Percutaneous Coronary Intervention

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02828137
Enrollment
123
Registered
2016-07-11
Start date
2009-05-31
Completion date
2014-12-31
Last updated
2016-08-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Death, Myocardial Infarction

Brief summary

The neutrophil-to-lymphocyte ratio (NLR) has been proven to be reliable inflammatory marker for atherosclerotic process and predictor for clinical outcomes in patients with various cardiovascular diseases. Recent study reported elevated NLR was associated with impaired myocardial perfusion in ST-segment elevation myocardial infarction (STEMI) patients. The investigators sought to determine whether NLR is associated with coronary microcirculation assessed by index of microcirculatory resistance (IMR) in STEMI patients who undergone primary percutaneous coronary intervention (PCI). A total of 123 patients with STEMI underwent successful primary PCI were consecutively enrolled. NLR at admission was calculated, and the patients were divided into three groups according to NLR tertiles. IMR was measured by intracoronary thermodilution-derived method immediately after index PCI.

Detailed description

A total of 123 consecutive STEMI patients who underwent successful primary PCI and coronary physiologic study immediately after PCI were retrospectively enrolled in the study. All patients underwent index PCI between May 2009 and October 2014 at INHA university hospital. The definition of STEMI was determined by the current guidelines. Complete blood counts, including total and differential WBC counts, were obtained at the time of admission. Total counts of WBC, neutrophils, and lymphocytes were assessed using an automated blood cell counter (XE-2100, Sysmex Inc., Japan). NLR was calculated as the ratio of the neutrophil counts to the lymphocyte counts. All patients were divided into 3 groups according to the NLR tertiles. The IMR was assessed shortly after primary PCI by using thermodilution-derived method. After successful interventional reperfusion, intracoronary nitroglycerin (100\ 200μg) was administered and coronary pressure guidewire (Radi Pressure Wire 5, Radi Medical Systems, Uppsala, Sweden) was calibrated outside the patient. The guidewire was equalized at the distal tip of guiding catheter, and then advanced towards the distal third of infarct related artery (IRA). Three times of saline injection (3\ 5 ml) were administered to IRA and baseline mean transit time was assessed. Microcirculatory hyperemia was induced by using an adenosine infusion (140 μg/kg.min) administered via peripheral venous line. During maximal hyperemia, hyperemic mean transit time (Tmn) was measured using same method as prior separate saline injections. Mean aortic (Pa) and distal coronary pressures (Pd) was measured during hyperemia. The IMR was calculated the formula as follows: IMR = Pd x hyperemic Tmn. Fractional flow reserve (FFR) was calculated by ratio of Pd to Pa during maximal hyperemic status. Coronary flow reserve (CFR) was derived from dividing the resting Tmn by hyperemic Tmn. Continuous variables were presented as mean ± standard deviation (SD) and categorical variables as the number of patients (percentages). The one way analysis of variance (ANOVA) was used for comparing continuous variables. Additionally, post-hoc analysis was performed for evaluating to be significant by ANOVA. The Pearson's chi-square test or Fisher's exact test was used for analyzing categorical variables. Linear regression analysis was performed for investigating the association between NLR and variables using clinical, laboratory, echocardiographic, and angiographic data. A p value \<0.05 was regarded statistically significant. All statistical analyses were carried out with SPSS version 19.0 (SPSS inc., Chicago, Illinois, USA).

Interventions

None listed

Sponsors

Inha University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
30 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* STEMI patients who undergone primary PCI

Exclusion criteria

* unprotected left main coronary artery disease * stent thrombosis presentation * a history of coronary artery bypass graft surgery * prior intravenous thrombolytic therapy before PCI * high degree atrioventricular block * remained cardiogenic shock after complete PCI * contraindication for use of adenosine * post-PCI thrombolysis in myocardial infarction (TIMI) flow grade 0 or 1

Design outcomes

Primary

MeasureTime frameDescription
Index of Microcirculatory Resistance3 monthsIMR in low NLR group : 21.94 ± 12.87 IMR in intermediate NLR group : 23.22 ± 12.73 IMR in high NLR group : 32.95 ± 20.60

Participant flow

Participants by arm

ArmCount
Low NLR Group
Neutrophil-to-Lymphocyte (NLR) Ratio \< 1.78
41
Intermediate NLR Group
1.78 \< Neutrophil-to-Lymphocyte (NLR) Ratio \< 3.90
41
High NLR Group
Neutrophil-to-Lymphocyte (NLR) Ratio \> 3.90
41
Total123

Baseline characteristics

CharacteristicLow NLR GroupHigh NLR GroupIntermediate NLR GroupTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
7 Participants11 Participants9 Participants27 Participants
Age, Categorical
Between 18 and 65 years
34 Participants30 Participants32 Participants96 Participants
Age, Continuous55 YEARS
STANDARD_DEVIATION 10
58 YEARS
STANDARD_DEVIATION 12
55 YEARS
STANDARD_DEVIATION 11
57 YEARS
STANDARD_DEVIATION 12
Region of Enrollment
Korea, Republic of
41 participants41 participants41 participants123 participants
Sex: Female, Male
Female
6 Participants3 Participants4 Participants13 Participants
Sex: Female, Male
Male
35 Participants38 Participants37 Participants110 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —
other
Total, other adverse events
0 / 00 / 00 / 0
serious
Total, serious adverse events
0 / 00 / 00 / 0

Outcome results

Primary

Index of Microcirculatory Resistance

IMR in low NLR group : 21.94 ± 12.87 IMR in intermediate NLR group : 23.22 ± 12.73 IMR in high NLR group : 32.95 ± 20.60

Time frame: 3 months

ArmMeasureValue (MEAN)Dispersion
Low NLR GroupIndex of Microcirculatory Resistance21.94 IMRStandard Deviation 12.87
Intermediate NLR GroupIndex of Microcirculatory Resistance23.22 IMRStandard Deviation 12.73
High NLR GroupIndex of Microcirculatory Resistance32.95 IMRStandard Deviation 20.6

Source: ClinicalTrials.gov · Data processed: Mar 12, 2026